There was no statistically significant difference when compared to sulfonylureas (HR = 1.13, CI: 0.952, 1.34) or insulin (HR = 1.02, CI: 0.947, 1.098), suggesting that other factors beyond metabolic control contribute to the likelihood of AD development. This evidence concerns the gene INS and Alzheimer disease.